This Week at FDA: Makary and a CRL for KalVista, More FDA Staff Leaving, Advisory Panels Slowed by Staff CutsJune 27, 2025July 10, 2025
FDA Requires New Warning on Common Allergy Drugs After Severe New Side Effect FoundMay 26, 2025May 26, 2025
